Atara Biotherapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Atara Biotherapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Atara Biotherapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 5.74M shares, a 94.4% decline year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 5.74M -96.2M -94.4% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 4.9M -96.2M -95.1% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 120M +23.8M +24.6% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 4.26M -91.7M -95.6% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 102M +7.04M +7.42% Sep 30, 2023 10-Q 2023-11-01
Q2 2023 101M +6.75M +7.15% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 96.5M +3.13M +3.35% Mar 31, 2023 10-Q 2023-05-08
Q4 2022 95.9M +4.26M +4.64% Dec 31, 2022 10-K 2024-03-28
Q3 2022 94.9M +6.49M +7.35% Sep 30, 2022 10-Q 2022-11-08
Q2 2022 94.4M +9.6M +11.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 93.4M +9.33M +11.1% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 91.7M +8.3M +9.95% Dec 31, 2021 10-K 2023-02-08
Q3 2021 88.4M +11.2M +14.5% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 84.8M +10.4M +14.1% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 84.1M +25.1M +42.6% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 83.4M +26.6M +46.8% Dec 31, 2020 10-K 2022-02-28
Q3 2020 77.2M +23.1M +42.7% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 74.3M +27.4M +58.5% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 58.9M +12.6M +27.3% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 56.8M +10.9M +23.6% Dec 31, 2019 10-K 2021-03-01
Q3 2019 54.1M +8.48M +18.6% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 46.9M +1.55M +3.42% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 46.3M +2.41M +5.5% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 46M +15.2M +49.5% Dec 31, 2018 10-K 2020-02-27
Q3 2018 45.6M +45.6M Sep 30, 2018 10-Q 2018-11-06
Q2 2018 45.3M +45.3M Jun 30, 2018 10-Q 2018-08-01
Q1 2018 43.9M +43.9M Mar 31, 2018 10-Q 2018-05-08
Q4 2017 30.7M +1.8M +6.21% Dec 31, 2017 10-K 2019-02-26
Q3 2017 30.6K* -28.8M Sep 30, 2017 10-Q 2017-11-09
Q2 2017 29.9K* -28.7M Jun 30, 2017 10-Q 2017-08-07
Q1 2017 29.1K* -28.6M Mar 31, 2017 10-Q 2017-05-04
Q4 2016 28.9M +474K +1.67% Dec 31, 2016 10-K 2018-02-27
Q3 2016 28.8M +516K +1.82% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 28.7M +4.55M +18.9% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 28.6M +4.67M +19.5% Mar 31, 2016 10-Q 2016-05-06
Q4 2015 28.5M +8.77M +44.5% Dec 31, 2015 10-K 2017-03-09
Q3 2015 28.3M +26.8M +1776% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 24.2M Jun 30, 2015 10-Q 2015-08-07
Q1 2015 23.9M Mar 31, 2015 10-Q 2015-05-11
Q4 2014 19.7M +7.69M +64.1% Dec 31, 2014 10-K 2016-03-04
Q3 2014 1.51M Sep 30, 2014 10-Q 2014-11-12
Q4 2013 12M Dec 31, 2013 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.